e60485441frm8k.htm
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): December 11, 2008
|
DELCATH
SYSTEMS, INC.
|
|
(Exact
Name of Registrant as Specified in
Charter)
|
|
DELAWARE
|
|
001-16133
|
|
06-1245881
|
|
(State
of Incorporation)
|
|
(Commission
File
Number)
|
|
(IRS
Employer
Identification No.)
|
|
600
FIFTH AVENUE, 23rd
FLOOR
NEW
YORK, NEW YORK
|
|
10020
|
|
(Address
of Principal Executive Offices)
|
|
(Zip
Code)
|
Registrant's
telephone number, including area code: (212) 489-2100
Check the
appropriate box below if the Form 8−K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
[ ]
Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
[ ]
Soliciting material pursuant to Rule 14a−12 under the Exchange Act (17 CFR
240.14a−12)
[ ]
Pre−commencement communications pursuant to Rule 14d−2(b) under the Exchange Act
(17 CFR 240.14d−2(b))
[ ]
Pre−commencement communications pursuant to Rule 13e−4(c) under the Exchange Act
(17 CFR 240.13e−4(c))
Item
5.02. Departure of Directors or Certain Officers;
Election of Directors; Appointment of Certain Officers; Compensatory
Arrangements of Certain Officers.
Effective
December 11, 2008 (the “Effective Date”), the Board of Directors of Delcath
Systems, Inc. (the “Company”) elected Pamela R. Contag as a
Director. Dr. Contag’s election was recommended by the Nominating
& Governance Committee and approved by the unanimous action of the full
Board of Directors. See Exhibit 99.1 attached hereto for biographical
information about Dr. Contag.
Dr.
Contag will receive standard director fees and benefits. In
addition, she was awarded on the Effective Date under the Company’s 2004 Stock
Incentive Plan (the “Plan”) options to purchase 75,000 shares of the Company’s
common stock at an exercise price per share equal to the Fair Market Value
thereof on the Effective Date determined in accordance with the
Plan. There are no other material transactions between Dr. Contag and
the Company.
Effective
December 13, 2008, the Company appointed Barbra C. Keck, 31, as the Company’s
Controller. Ms. Keck received her MBA in accounting in August of this year from
Baruch College. Most recently, Ms. Keck has been an audit assistant with
Deloitte & Touche LLP since September 2008, prior to which she was a student
for her MBA since September 2006. In addition, from 2006 until 2008, Ms. Keck
was an assistant to the Vice President and Dean of Baruch College. From 2005 to
2006, Ms. Keck was a donor relations and communications manager at Young
Audiences New York, a nonprofit organization that works with educational
systems, the arts community and private and public sectors to provide arts
education to children and, from 2003 to 2005, she was a manager of arts and
cultural events for the University of Dayton.
Item
9.01. Financial Statements and Exhibits
|
Exhibit
Number
|
Description
|
|
99.1
|
Press
Release
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the Registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly
authorized.
Date: December
16, 2008
| |
DELCATH
SYSTEMS, INC. |
|
| |
|
|
|
| |
|
|
|
|
|
By:
|
/s/
Richard L. Taney |
|
| |
|
Name:
Richard L. Taney |
|
| |
|
Title:
Chief Executive Officer |
|
| |
|
|
|
3